Aptamer Group works with the top 10 pharmaceutical companies and leading organisations to accelerate drug discovery, advance clinical development, and solve critical challenges in therapeutics, diagnostics, and bioprocessing. The company's proprietary Optimer® technology platform delivers synthetic binders engineered for rapid development timelines, batch consistency, cost-effective manufacturability, and access to challenging targets beyond the reach of traditional antibodies.
The company embraces a dynamic, entrepreneurial approach and offers career opportunities for high-calibre graduates and experienced science and commercial professionals, with potential for significant corporate growth and career development. Aptamer Group has established royalty-bearing licenses and repeat partnerships, building value through innovation across neurology, oncology, metabolism, and radiopharmaceuticals.
This is the employer describing itself, in its own words. We do not rate or review employers, and nothing here is our opinion of one.